We develop state-of-the-art mRNA-based molecular diagnostics for cancer detection, therapy recommendation, and monitoring. Our current tests are for Neuroendocrine tumors, NET PPQ and a saliva-based diagnostic for Covid-19. We anticipate offering a molecular prostate cancer diagnostic very soon, and have other solid-tumor diagnostics in our pipeline.[ https://wrenlaboratories.com/ ]Wren also offers a very accurate and easy-to-use Covid-19 testing solution.[ https://wrencovidtesting.com/ ]